$78.8 Million is the total value of CARNEGIE MELLON UNIVERSITY's 7 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | DUOLINGO INC | $60,926,373 | +15.4% | 367,314 | -0.6% | 77.33% | +4.0% | |
| IEMG | ISHARES INCcore msci emkt | $17,184,892 | -3.4% | 361,103 | 0.0% | 21.81% | -13.0% | |
| New | CARMELL THERAPEUTICS CORPcl a | $371,329 | – | 103,061 | +100.0% | 0.47% | – | |
| VERA | VERA THERAPEUTICS INC.cl a | $220,183 | -14.6% | 16,060 | 0.0% | 0.28% | -23.1% | |
| NBSE | NEUBASE THERAPEUTICS INC. | $40,855 | -53.5% | 46,970 | 0.0% | 0.05% | -58.1% | |
| PREDICTIVE ONCOLOGY INC. | $33,146 | -34.2% | 10,358 | 0.0% | 0.04% | -40.8% | ||
| IHT | INNSUITES HOSPITALITY TRUSTsh ben int | $12,700 | -46.9% | 10,000 | 0.0% | 0.02% | -52.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-01
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES INC | 8 | Q3 2023 | 79.8% |
| DUOLINGO INC | 8 | Q3 2023 | 77.3% |
| NEUBASE THERAPEUTICS INC. | 8 | Q3 2023 | 1.1% |
| VERA THERAPEUTICS INC. | 8 | Q3 2023 | 0.4% |
| PREDICTIVE ONCOLOGY INC. | 8 | Q3 2023 | 0.1% |
| INNSUITES HOSPITALITY TRUST | 8 | Q3 2023 | 0.0% |
| CARMELL THERAPEUTICS CORP | 1 | Q3 2023 | 0.5% |
View CARNEGIE MELLON UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NeuBase Therapeutics, Inc. | July 22, 2019 | 939,412 | 5.5% |
View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-01 |
| 13F-HR | 2023-05-03 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-11 |
| SC 13G | 2019-07-22 |
View CARNEGIE MELLON UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.